Metalloproteinase-like,
, are critical to tissue morphogenesis and remodeling, including pathologic processes such as the formation of lesions of atherosclerosis.
The family of metalloproteinase-like, disintegrin-like, cysteine-rich proteins [MDC, also known as ADAM (5) ]2 have a primary structure that suggests they may be novel modulators of cell-cell and cell-matrix interactions.
Several reported MDCs have an active site motif in their metalloproteinase domain similar to snake venom hemorrhagic proteinases, which can digest a wide variety of matrix molecules (6) (7) (8) (9) . The disintegrin-like domain of MDCs is related to the long-chain non-RGD snake venom disintegrins (10) , some of which are known to interact with a2f31 integrin (11) . In contrast to the soluble snake venom metalloproteinases and disintegrins, MDCs are transmembrane proteins. Consequently, their activity may be spatially more restricted and they may be involved in signal transduction.
Three members of this family, the fertilin a/13heterodimer, and meltrin a, appear to be involved in cell-cell fusion (12, 13) . In addition, the putative tumor suppressor gene MDC was shown to be somatically rearranged in two primary breast tumors (14) . 
RT-PCR
Human aortic smooth muscle cells were allowed to adhere to monomer type I collagen (dishes coated with 100 tg/ml Vitrogen in 0. insert as a probe. Positive plaques were isolated and purified by two rounds of plaque assay as described (16) . Lambda DNA was isolated and purified using the QIAGEN lambda kit, and purified DNA was digested with Eco RI and separated on a 1% agarose gel.
Inserts
were isolated using Geneclean (BIO 101, La Jolla, Calif.), subcloned into pGEM3Z (Promega), and sequenced as described above.
.86 . 
Protein analysis
Cell lysates were prepared by incubating the cells for 5 mm on ice with 0.5% NP-40 in Iris-buffered saline, pH 7, 5 mM EDTA, 1 mM PMSF, 2 p.g/ml pepstatin A, 2 p.g/ml leupeptin, 4 p.g/ml aprotinin, and 10 p.g/ ml soybean trypsin inhibitor, scraping off the cells and centrifuging at 16 ,000 X g to remove cellular debris. Lysates were recalcified and then incubated with 150 p.1 Con A Sepharose (for lysate from 12-16X 106 cells); the Con A Sepharose was washed well with recalcified lysis buffer, followed by elution by boiling with 2X SDS sample buffer. Lysates from 1-2 X 106 cells were run on a 10% SDS gel and transferred to Immobilon membrane (Millipore Corp., Milford, Mass.) blotting. As shown in Fig. 1 , mRNA levels of 7.11.10 are about three-to fivefold higher in HUVECs than in aortic SMCs. We also evaluated changes in mRNA levels with attachment to different matrices at different cell densities and after cytokine and growth factor treatment (Fig. 2) . Attachment of SMCs to type I collagen ( Fig. 2A) or fibronectin (data not shown) in the presence or absence of PDGF-BB and insulin-like growth factor I (IGF-I) did not alter 7.11.10 mRNA levels. Although lipopolysaccharide (LPS) and cytokine treatment of HUVECs have been shown to induce the expression of a number of endothelial cell-surface proteins, including endothelial-leukocyte adhesion molecules (21), they did not alter mRNA levels of 7.11.10. Differences in cell densities and multi-scratch wounding also failed to regulate 7.11.10 mRNA levels (Fig. 2B) .
The sequence of MDC 15 isolated from cultured human endothelial cells
The full-length cDNA for 7.11.10 was isolated from HU-VEC eDNA libraries and by PCR amplification.
One clone was obtained from an oligo dT primed library and one from a random hexamer primed library, which together encompassed about 2.3 kb of sequence.
As the 3' end was missing from this clone, we performed a 3' rapid amplification of cDNA ends (3'RACE) using a sense oligonucleotide close to the 3' end of the A. (13, 23, 24) . Therefore, processing of MDC 15 was analyzed for different HUVEC strains isolated from different donors using polyclonal antibodies raised against peptides from different domains of MDC 15. In both strains shown in Fig. 4 , the antibody to the disintegrin-like peptide (antidis) recognized the proform of approx. 110 kDa) , MDC 15 lacking the prodomain (zpro, approx. 75 kDa), and MDC 15 lacking the prodomain and the metalloproteinase (zme, approx. 48 kDa). The antibody to the metalloproteinase peptide recognized the pro and pro forms in strain 1, whereas in strain 2, an additional band was recognized (approx. 54 kDa), which probably represents a cell-associated prodomain plus a metalloproteinase domain. The processing observed in strain 1 has been seen in two of seven isolates and that of strain 2 in five of seven isolates.
Expression of MDC 15 protein in lesions of atherosclerosis
To examine whether MDC 15 expression is altered in the development of lesions of atherosclerosis, sections from normal and hypercholesterolemic nonhuman primates (Macaca nemestrina) were stained using the purified antibodies against the cytoplasmic peptide and the EGF-like domain. Although no staining could be detected in normal aorta (Fig. 5A) , both antibodies demonstrated similar staining of cells in the macrophage-rich core (Fig. 5B, E,   F) , as well as some intimal staining closer to the lumen (Fig. 5B, D) . The primary structure of MDC 15 ( Fig. 3) predicts a transmembrane protein with a catalytic consensus motif in the metalloproteinase domain (26-28), a disintegrin-like domain with an RGD in the putative integrin binding site (29), and several putative SH3 binding sequences as well as potential Ser/Thr phosphorylation sites in the cytoplasmic domain (30) (31) (32) (33) (34) that may modulate cell function (Table 1). A potential furin cleavage site of four Arg residues exists between the prodomain and the metalloproteinase domain that could lead to removal of the prodomain and activation of the metalloproteinase if furin is also expressed (35). Evidence for such cleavage has been observed in all strains of HUVECs that were analyzed.
DISCUSSION
Hemorrhagic snake venom metalloproteinases can digest a wide variety of matrix molecules, although they have low proteolytic activity for interstitial collagen (6-9). It is possible that the metalloproteinase of MDC 15 has a similarly broad specificity because, like all other MDCs, it is related to the family of snake venom proteinases (29 Putative protein kinase substrate recognition sites on MDC 15 For several members of the MDC family of proteins, proteolytic processing has been shown to occur (13, 23, 24) . In two strains of HUVECs evaluated in this study that were isolated from two different donors, evidence for differential processing by the two strains was obtained, although no gross morphologic difference between them was apparent. This differential processing has been confirmed in additional endothelial cell strains. The size and antibody recognition of bands in the two strains suggest that the approximately 75 kDa band represents a membrane-bound metalloproteinase lacking the prodomain. Therefore, strain 1 appears to express both a surface-bound, potentially activated metalloproteinase and a form lacking the metalloproteinase domain. In strain 2, most of the metalloproteinase does not seem to be bound to the further COOHterminal domains. Instead, the -'54 kDa band recognized only by the antiserum against the metalloproteinase peptide suggests that it remains bound to the prodomain and that the two domains remain cell associated by an as yet unidentified mechanism.
Processing of MDC 15 may regulate its activity
For fertilin, as well as meltrin a, processing appears to be associated with activation of the MDCs (13, 23 and matrix degradation by its metalloproteinase domain (zn2+.U). which may lead to signal transduction. B) Proteolysis may also release the metalloproteinase domain from the cell surface, which may then locally, or after diffusion, degrade matrix. The cell surface-bound part of MDC 15 may be involved in signal transduction (see Table 1 ) and cell-cell interaction.
Binding of MDC 15 to integrins on the same cell cannot be excluded. C) If the disintegrin-like and metalloproteinase domains were released from the cell surface, the disintegrin-like domain may target a proteolytically active metalloproteinase to sites of integrin/matrix interactions, where they might simultaneously degrade matrix and inhibit integrmn binding to matrix, thereby facilitating cell migration.
